These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 15910887

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evidence that (-)-7-hydroxy-4'-dimethylheptyl-cannabidiol activates a non-CB(1), non-CB(2), non-TRPV1 target in the mouse vas deferens.
    Pertwee RG, Thomas A, Stevenson LA, Maor Y, Mechoulam R.
    Neuropharmacology; 2005 Jun; 48(8):1139-46. PubMed ID: 15910889
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists.
    Roser P, Vollenweider FX, Kawohl W.
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):208-19. PubMed ID: 20218784
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
    Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V.
    Br J Pharmacol; 2001 Oct; 134(4):845-52. PubMed ID: 11606325
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.
    Wiley JL, Selley DE, Wang P, Kottani R, Gadthula S, Mahadeven A.
    J Pharmacol Exp Ther; 2012 Feb; 340(2):433-44. PubMed ID: 22085649
    [Abstract] [Full Text] [Related]

  • 13. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
    Haller VL, Cichewicz DL, Welch SP.
    Eur J Pharmacol; 2006 Sep 28; 546(1-3):60-8. PubMed ID: 16919265
    [Abstract] [Full Text] [Related]

  • 14. Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase.
    de Filippis D, Iuvone T, d'amico A, Esposito G, Steardo L, Herman AG, Pelckmans PA, de Winter BY, de Man JG.
    Neurogastroenterol Motil; 2008 Aug 28; 20(8):919-27. PubMed ID: 18373655
    [Abstract] [Full Text] [Related]

  • 15. The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors.
    Castillo A, Tolón MR, Fernández-Ruiz J, Romero J, Martinez-Orgado J.
    Neurobiol Dis; 2010 Feb 28; 37(2):434-40. PubMed ID: 19900555
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.
    Cox ML, Haller VL, Welch SP.
    Eur J Pharmacol; 2007 Sep 10; 570(1-3):50-6. PubMed ID: 17588560
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents.
    Bi GH, Galaj E, He Y, Xi ZX.
    Addict Biol; 2020 Jul 10; 25(4):e12783. PubMed ID: 31215752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.